112 related articles for article (PubMed ID: 35985444)
1. CPNE1 silencing inhibits cell proliferation and accelerates apoptosis in human gastric cancer.
Li Y; Li L; Liu H; Zhou T
Eur J Pharm Sci; 2022 Oct; 177():106278. PubMed ID: 35985444
[TBL] [Abstract][Full Text] [Related]
2. Silencing of CPNE1-TRAF2 Axis Restrains the Development of Pancreatic Cancer.
Song Y; Song B; Yu Z; Li A; Xia L; Zhao Y; Lu Z; Li Z
Front Biosci (Landmark Ed); 2023 Nov; 28(11):316. PubMed ID: 38062811
[TBL] [Abstract][Full Text] [Related]
3. CPNE1 predicts poor prognosis and promotes tumorigenesis and radioresistance via the AKT singling pathway in triple-negative breast cancer.
Shao Z; Ma X; Zhang Y; Sun Y; Lv W; He K; Xia R; Wang P; Gao X
Mol Carcinog; 2020 May; 59(5):533-544. PubMed ID: 32181526
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of AP-4 inhibits proliferation, induces cell cycle arrest and promotes apoptosis in human gastric cancer cells.
Liu X; Zhang B; Guo Y; Liang Q; Wu C; Wu L; Tao K; Wang G; Chen J
PLoS One; 2012; 7(5):e37096. PubMed ID: 22615908
[TBL] [Abstract][Full Text] [Related]
5. CPNE1 is a target of miR-335-5p and plays an important role in the pathogenesis of non-small cell lung cancer.
Tang H; Zhu J; Du W; Liu S; Zeng Y; Ding Z; Zhang Y; Wang X; Liu Z; Huang J
J Exp Clin Cancer Res; 2018 Jul; 37(1):131. PubMed ID: 29970127
[TBL] [Abstract][Full Text] [Related]
6. Silencing of COPB2 inhibits the proliferation of gastric cancer cells and induces apoptosis via suppression of the RTK signaling pathway.
An C; Li H; Zhang X; Wang J; Qiang Y; Ye X; Li Q; Guan Q; Zhou Y
Int J Oncol; 2019 Apr; 54(4):1195-1208. PubMed ID: 30968146
[TBL] [Abstract][Full Text] [Related]
7. CHSY1 is upregulated and acts as tumor promotor in gastric cancer through regulating cell proliferation, apoptosis, and migration.
Liu J; Tian Z; Liu T; Wen D; Ma Z; Liu Y; Zhu J
Cell Cycle; 2021 Sep; 20(18):1861-1874. PubMed ID: 34412565
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA HOXA-AS2 promotes gastric cancer proliferation by epigenetically silencing P21/PLK3/DDIT3 expression.
Xie M; Sun M; Zhu YN; Xia R; Liu YW; Ding J; Ma HW; He XZ; Zhang ZH; Liu ZJ; Liu XH; De W
Oncotarget; 2015 Oct; 6(32):33587-601. PubMed ID: 26384350
[TBL] [Abstract][Full Text] [Related]
9. CPNE1 promotes non-small cell lung cancer progression by interacting with RACK1 via the MET signaling pathway.
Wang A; Yang W; Li Y; Zhang Y; Zhou J; Zhang R; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA
Cell Commun Signal; 2022 Jan; 20(1):16. PubMed ID: 35101055
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer.
Sun M; Jin FY; Xia R; Kong R; Li JH; Xu TP; Liu YW; Zhang EB; Liu XH; De W
BMC Cancer; 2014 May; 14():319. PubMed ID: 24884417
[TBL] [Abstract][Full Text] [Related]
11. Piperine Inhibits Cell Proliferation and Induces Apoptosis of Human Gastric Cancer Cells by Downregulating Phosphatidylinositol 3-Kinase (PI3K)/Akt Pathway.
Chen H; Sheng H; Zhao Y; Zhu G
Med Sci Monit; 2020 Dec; 26():e928403. PubMed ID: 33382670
[TBL] [Abstract][Full Text] [Related]
12. Growth arrest-specific gene 1 is downregulated and inhibits tumor growth in gastric cancer.
Wang H; Zhou X; Zhang Y; Zhu H; Zhao L; Fan L; Wang Y; Gang Y; Wu K; Liu Z; Fan D
FEBS J; 2012 Oct; 279(19):3652-3664. PubMed ID: 22846196
[TBL] [Abstract][Full Text] [Related]
13. Exploring the role of copine 1 in human colorectal cancer: investigating its association with tumorigenesis and metastasis.
Lee JK; Lee SJ; Hah YS; Ji YH; Ju YT; Lee YJ; Jeong CY; Kim JY; Park JH; Kim JM; Cho JK; Kim HG; Kwag SJ
Ann Surg Treat Res; 2023 Dec; 105(6):385-395. PubMed ID: 38076599
[TBL] [Abstract][Full Text] [Related]
14. Anti-proliferation effects of Twist gene silencing in gastric cancer SGC7901 cells.
Zhang H; Gong J; Kong D; Liu HY
World J Gastroenterol; 2015 Mar; 21(10):2926-36. PubMed ID: 25780290
[TBL] [Abstract][Full Text] [Related]
15. Survivin inhibitor YM155 suppresses gastric cancer xenograft growth in mice without affecting normal tissues.
Cheng XJ; Lin JC; Ding YF; Zhu L; Ye J; Tu SP
Oncotarget; 2016 Feb; 7(6):7096-109. PubMed ID: 26771139
[TBL] [Abstract][Full Text] [Related]
16. Copine 1 predicts poor clinical outcomes by promoting M2 macrophage activation in ovarian cancer.
Sheng B; Zhao B; Dong Y; Zhang J; Wu S; Ji H; Zhu X
Carcinogenesis; 2023 Dec; 44(10-11):748-759. PubMed ID: 37747823
[TBL] [Abstract][Full Text] [Related]
17. CPNE1 silencing inhibits the proliferation, invasion and migration of human osteosarcoma cells.
Jiang Z; Jiang J; Zhao B; Yang H; Wang Y; Guo S; Deng Y; Lu D; Ma T; Wang H; Wang J
Oncol Rep; 2018 Feb; 39(2):643-650. PubMed ID: 29207139
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg5 induces G2/M phase arrest, apoptosis and autophagy via regulating ROS-mediated MAPK pathways against human gastric cancer.
Liu Y; Fan D
Biochem Pharmacol; 2019 Oct; 168():285-304. PubMed ID: 31301277
[TBL] [Abstract][Full Text] [Related]
19. Overexpressed CISD2 has prognostic value in human gastric cancer and promotes gastric cancer cell proliferation and tumorigenesis via AKT signaling pathway.
Wang L; Ouyang F; Liu X; Wu S; Wu HM; Xu Y; Wang B; Zhu J; Xu X; Zhang L
Oncotarget; 2016 Jan; 7(4):3791-805. PubMed ID: 26565812
[TBL] [Abstract][Full Text] [Related]
20. CPNE1 Enhances Colorectal Cancer Cell Growth, Glycolysis, and Drug Resistance Through Regulating the AKT-GLUT1/HK2 Pathway.
Wang Y; Pan S; He X; Wang Y; Huang H; Chen J; Zhang Y; Zhang Z; Qin X
Onco Targets Ther; 2021; 14():699-710. PubMed ID: 33536762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
